NSEGeneral Updates23 Jun 2026 · 23 Jun 2026, 06:31 pm
General Updates
Bajaj Healthcare Limited · BAJAJHCARE
✦ AI SummaryDivestiture
Bajaj Healthcare Limited has approved the sale of an operational business unit located in Tarapur for up to ₹4.05 Crores, with completion expected by October 31, 2026. This unit contributed a minor 0.54% to the company's revenue and 0.74% to its net worth in the last financial year, indicating a negligible financial impact. The buyer, M/s Orchem Products, is an unrelated party, and the transaction is not considered a related party transaction.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bajaj Healthcare Limited has informed the Exchange about General Updates
Attachments (1)
📄pdf
Download →
BAJAJHCARE_23062026183057_Intimation.pdf
View document text
Ref: BHL/ STEX 12/ 2026-27
Date: June 23, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers 5th Floor, Exchange Plaza,
Dalal Street Bandra Kurla Complex Bandra (East)
Mumbai-400001 Mumbai-400051
Scrip Code: 539872 Symbol: BAJAJHCARE
Dear Sir/Madam,
Subject: Intimation for Sale of Operational Business Unit pursuant to Regulation 30 of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations 2015, we hereby inform you that the Board of
Directors of the Company by way of a resolution passed by circulation on June 23, 2026, has approved
the sale of the operational business unit of the Company situated at Plot No. N-178, MIDC, Tarapur
Industrial Area, Tarapur, Boisar, Palghar-401 506, subject to the execution of definitive transaction
documents.
Further, we hereby confirm that none of the promoter/ promoter group/ group companies has any interest
in the aforesaid entity and the transaction does not fall within the purview of Related Party Transactions.
Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the
Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading
in Securities, the Trading Window for dealing in the securities of Bajaj Healthcare Limited shall remain
closed for all Directors, Designated Persons and their immediate relatives from immediate effect till the
expiry of 48 hours from the date of formal execution and signing of definitive agreements.
The brief details, in accordance with the SEBI Listing Regulations read with SEBI Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are enclosed as “Annexure-I”.
You are requested to take the same on record.
Thanking You,
For and on behalf of Bajaj Healthcare Limited
Monica Tanwar
Company Secretary & Compliance Officer
Encl: as above
BAJAJ HEALTHCARE LIMITED
Registered Office: 602-606, Bhoomi Velocity Infotech Park, Plot No: B-39, B-39A, B-39A/1, Road No. 23, Wagle Ind. Estate, Thane (West), Thane - 400604
Tel. : + 91 22 66177400/ 401; Fax : +91 22 66177458; E-mail : bajajhealth@bajajhealth.com
CIN No. L99999MH1993PLC072892
Annexure-I
Details required under the Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-
CFD-POD2/I/3762/2026 dated January 30, 2026
Sr. Particulars Details
a) The amount and percentage of the turnover or Amount of the Revenue: 3.31 Crores
revenue or income and net worth contributed by Percentage of Revenue: 0.54%
such unit or division or undertaking or subsidiary or
associate company of the listed entity during the last Amount of Net-Worth: 3.97 Crores
financial year Percentage of Net-Worth: 0.74%
b) Date on which the agreement for sale has been Not Applicable
entered into
c) The expected date of completion of sale/disposal The transaction is expected to be
completed on or before 31st October
2026.
d) Consideration received from such sale/disposal The consideration will be upto ₹4.05
Crores (Rupees Four Crores and Five
Lakhs Only)
e) Brief details of buyers and whether any of the buyers The Buyer is M/s Orchem Products which
belong to the promoter/ promoter group/group does not belong to the Promoter/Promoter
companies. If yes, details thereof Group/ Group companies and the
transaction does not fall within the
purview of Related Party Transactions.
f) Whether the transaction would fall within related No
party transactions? If yes, whether the same is done
at “arm’s length”
g) Whether the sale, lease or disposal of the Not Applicable.
undertaking is outside Scheme of Arrangement? If
yes, details of the same including compliance with The Sale of Unit does not fall under the
regulation 37A of LODR Regulations. definition of an “Undertaking” as per the
provisions of the Companies Act, 2013.
h) Additionally, in case of a slump sale, indicative Not Applicable
disclosures provided for amalgamation/merger, shall
be disclosed by the listed entity with respect to such
slump sale.
BAJAJ HEALTHCARE LIMITED
Registered Office: 602-606, Bhoomi Velocity Infotech Park, Plot No: B-39, B-39A, B-39A/1, Road No. 23, Wagle Ind. Estate, Thane (West), Thane - 400604
Tel. : + 91 22 66177400/ 401; Fax : +91 22 66177458; E-mail : bajajhealth@bajajhealth.com
CIN No. L99999MH1993PLC072892